S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Stopped early · Phase 1

Conditions studied: Brain Tumors, Gastric Cancer, Ovarian Cancer, Prostate Cancer

In brief

RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying two different vaccines to treat patients who have gastric, prostate, or ovarian cancer.

Key facts

Study ID

NCT00023634

Run by

SWOG Cancer Research Network

People needed

14

Starts

2001-06-01

Expected to finish

2008-11-01

Last updated by the study team

2015-03-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Bay Regional Medical Center — Bay City, Michigan, United States
• Mercy Regional Cancer Center at Mercy Hospital — Port Huron, Michigan, United States
• St. Joseph Hospital Community Cancer Center — Bellingham, Washington, United States
• Olympic Hematology and Oncology — Bremerton, Washington, United States
• Skagit Valley Hospital Cancer Care Center — Mount Vernon, Washington, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
• Harborview Medical Center — Seattle, Washington, United States
• Group Health Central Hospital — Seattle, Washington, United States
• Swedish Cancer Institute at Swedish Medical Center - First Hill Campus — Seattle, Washington, United States
• University Cancer Center at University of Washington Medical Center — Seattle, Washington, United States
• North Puget Oncology at United General Hospital — Sedro-Woolley, Washington, United States
• Cancer Care Northwest - Spokane South — Spokane, Washington, United States
• Wenatchee Valley Clinic — Wenatchee, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.